Podcast Episodes
Back to SearchENCORE: A New Revolutionary Technology That Can Predict Cardiovascular Risk With Precision, Part 2
Dr. Hoffman continues his conversation with Dr. James Min, an expert on cardiovascular imaging and founder and CEO of Cleerly, a company that has dev…
2 years, 1 month ago
ENCORE: Intelligent Medicine Radio for May 4, Part 1: The Debate Over “Moderate Drinking”
The Standard American Diet (SAD) is truly sad; Twin experiment reveals health and mood tolls of ultra-processed food; Can Jets’ Aaron Rodgers make a …
2 years, 1 month ago
ENCORE: Intelligent Medicine Radio for May 4, Part 2: Chat GPT for Cancer Treatment Options?
Why you shouldn’t rely on Chat GPT for cancer treatment options; How stress undermines your immune system defense against cancer; Keto diet + supplem…
2 years, 1 month ago
Leyla Weighs In: Decoding Food Allergies, Intolerances, and Sensitivities
"Leyla Weighs In: on the differences between food allergies, sensitivities, and intolerances, highlighting the immune responses involved and common t…
2 years, 1 month ago
ENCORE: Q&A with Leyla, Part 1: Selfies and Plastic Surgery
Selfies are driving up plastic surgery; Are either glucosamine hydrochloride or potassium sulfate bad for you--especially after long-term use?; What …
2 years, 1 month ago
ENCORE: Q&A with Leyla, Part 2: Varicose Veins
Use of magnesium in Crohn's disease; Study: Association of habitual alcohol intake with risk of cardiovascular disease; If one is taking vitamin C, i…
2 years, 1 month ago
ENCORE: A Novel, Newly-Discovered Nutraceutical, Part 1
The Annatto plant is valued as a rich source of tocotrienols and a novel, newly-discovered nutraceutical: geranylgeraniol (GG). Dr. Barrie Tan, a Ph.…
2 years, 1 month ago
ENCORE: A Novel, Newly-Discovered Nutraceutical, Part 2
Dr. Hoffman continues his conversation with Dr. Barrie Tan, a Ph.D. biochemist who discovered GG, and Dr. David Brady, former director of the Human N…
2 years, 1 month ago
ENCORE: A New Way of Understanding Patients With a Wide Array of Elusive Symptoms, Part 1
Mast Cell Activation Syndrome (MCAS) is a diagnosis that offers a new way of understanding patients with a wide array of elusive symptoms, resistant …
2 years, 1 month ago
ENCORE: A New Way of Understanding Patients With a Wide Array of Elusive Symptoms, Part 2
Dr. Hoffman continues his conversation with Dr. Tania Dempsey, an expert in dealing with complex diseases, about Mast Cell Activation Syndrome (MCAS).
2 years, 1 month ago